Table 4

Validation of the differentially expressed miRNAs in T and B cells by quantitative PCR

Discovery cohortReplication cohortCombined analysis
miRNAsFold changep ValuemiRNAsp ValuemiRNAsp Value
T cells
hsa-let-7d-3p−2.365.58×10−7 hsa-let-7d-3p0.008hsa-let-7d-3p1.32×10−8
hsa-miR-28-5p1.140.014hsa-miR-28-5p0.030hsa-miR-28-5p6.23×10−4
hsa-miR-378a-3p−1.509.93×10−5 hsa-miR-378a-3p0.029hsa-miR-378a-3p9.94×10−6
hsa-miR-26a-5p −1.15 0.075 hsa-miR-26a-5p0.046hsa-miR-26a-5p0.008
hsa-miR-30b-5p−1.190.036 hsa-miR-30b-5p 0.378 hsa-miR-30b-5p0.026
hsa-miR-140-3p1.130.018 hsa-miR-140-3p 0.389 hsa-miR-140-3p0.018
hsa-miR-30c-5p−1.100.019hsa-miR-30c-5p0.019hsa-miR-30c-5p0.006
hsa-miR-155-5p1.310.004hsa-miR-155-5p0.009hsa-miR-155-5p2.17×10−4
hsa-miR-31-3p−1.440.043 hsa-miR-31-3p 0.312 hsa-miR-31-3p0.011
hsa-miR-222-3p1.220.025hsa-miR-222-3p0.009hsa-miR-222-3p6.60×10−4
hsa-miR-16-5p1.187.26×10−4 hsa-miR-16-5p 0.829 hsa-miR-16-5p 0.669
hsa-miR-146a-5p1.300.017hsa-miR-146a-5p0.021hsa-miR-146a-5p0.001
B cells
hsa-miR-30b-5p−1.590.003hsa-miR-30b-5p0.012hsa-miR-30b-5p4.16×10−5
hsa-miR-222-3p1.320.002hsa-miR-222-3p0.005hsa-miR-222-3p1.62×10−5
hsa-miR-18a-3p1.280.027 hsa-miR-18a-3p 0.137 hsa-miR-18a-3p 0.613
hsa-miR-19b-3p−1.380.012hsa-miR-19b-3p0.028hsa-miR-19b-3p4.87×10−4
hsa-miR-26a-5p−1.370.013hsa-miR-26a-5p0.006hsa-miR-26a-5p9.85×10−5
hsa-miR-20a-5p −1.14 0.082 hsa-miR-20a-5p0.019hsa-miR-20a-5p0.002
hsa-miR-32-5p−1.750.014 hsa-miR-32-5p 0.416 hsa-miR-32-5p0.038
hsa-let-7d-3p−2.032.12×10−4 hsa-let-7d-3p 0.452 hsa-let-7d-3p0.024
hsa-miR-378a-3p −1.29 0.062 hsa-miR-378a-3p3.11×10−4 hsa-miR-378a-3p5.49×10−6
hsa-miR-146a-5p−1.350.024 hsa-miR-146a-5p 0.157 hsa-miR-146a-5p0.008
  • Differentially expressed miRNAs found in the discovery cohort and in the replication cohort are shown. MiRNAs in black depict those with a p value<0.05 and miRNAs in grey depict those with p value>0.05. Nominal p values without correction for multiple comparisons are shown.

  • miRNA, microRNA; pSS, primary Sjögren’s syndrome.